308 related articles for article (PubMed ID: 35663962)
1. The Specific Mechanism of TREM2 Regulation of Synaptic Clearance in Alzheimer's Disease.
Qin Q; Wang M; Yin Y; Tang Y
Front Immunol; 2022; 13():845897. PubMed ID: 35663962
[TBL] [Abstract][Full Text] [Related]
2. The Role of APOE and TREM2 in Alzheimer's Disease-Current Understanding and Perspectives.
Wolfe CM; Fitz NF; Nam KN; Lefterov I; Koldamova R
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30587772
[TBL] [Abstract][Full Text] [Related]
3. TREM2 receptor protects against complement-mediated synaptic loss by binding to complement C1q during neurodegeneration.
Zhong L; Sheng X; Wang W; Li Y; Zhuo R; Wang K; Zhang L; Hu DD; Hong Y; Chen L; Rao H; Li T; Chen M; Lin Z; Zhang YW; Wang X; Yan XX; Chen X; Bu G; Chen XF
Immunity; 2023 Aug; 56(8):1794-1808.e8. PubMed ID: 37442133
[TBL] [Abstract][Full Text] [Related]
4. TREM2: Potential therapeutic targeting of microglia for Alzheimer's disease.
Li Y; Xu H; Wang H; Yang K; Luan J; Wang S
Biomed Pharmacother; 2023 Sep; 165():115218. PubMed ID: 37517293
[TBL] [Abstract][Full Text] [Related]
5. The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases.
Krasemann S; Madore C; Cialic R; Baufeld C; Calcagno N; El Fatimy R; Beckers L; O'Loughlin E; Xu Y; Fanek Z; Greco DJ; Smith ST; Tweet G; Humulock Z; Zrzavy T; Conde-Sanroman P; Gacias M; Weng Z; Chen H; Tjon E; Mazaheri F; Hartmann K; Madi A; Ulrich JD; Glatzel M; Worthmann A; Heeren J; Budnik B; Lemere C; Ikezu T; Heppner FL; Litvak V; Holtzman DM; Lassmann H; Weiner HL; Ochando J; Haass C; Butovsky O
Immunity; 2017 Sep; 47(3):566-581.e9. PubMed ID: 28930663
[TBL] [Abstract][Full Text] [Related]
6. TREM2, microglia, and Alzheimer's disease.
Qin Q; Teng Z; Liu C; Li Q; Yin Y; Tang Y
Mech Ageing Dev; 2021 Apr; 195():111438. PubMed ID: 33516818
[TBL] [Abstract][Full Text] [Related]
7. TREM2 and Microglia Contribute to the Synaptic Plasticity: from Physiology to Pathology.
Yu CJ; Wang M; Li RY; Wei T; Yang HC; Yin YS; Mi YX; Qin Q; Tang Y
Mol Neurobiol; 2023 Feb; 60(2):512-523. PubMed ID: 36318443
[TBL] [Abstract][Full Text] [Related]
8. TREM2 and the neuroimmunology of Alzheimer's disease.
Hickman SE; El Khoury J
Biochem Pharmacol; 2014 Apr; 88(4):495-8. PubMed ID: 24355566
[TBL] [Abstract][Full Text] [Related]
9. Microglial Trem2 induces synaptic impairment at early stage and prevents amyloidosis at late stage in APP/PS1 mice.
Sheng L; Chen M; Cai K; Song Y; Yu D; Zhang H; Xu G
FASEB J; 2019 Sep; 33(9):10425-10442. PubMed ID: 31219699
[TBL] [Abstract][Full Text] [Related]
10. APOE and TREM2 regulate amyloid-responsive microglia in Alzheimer's disease.
Nguyen AT; Wang K; Hu G; Wang X; Miao Z; Azevedo JA; Suh E; Van Deerlin VM; Choi D; Roeder K; Li M; Lee EB
Acta Neuropathol; 2020 Oct; 140(4):477-493. PubMed ID: 32840654
[TBL] [Abstract][Full Text] [Related]
11. Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice.
Fitz NF; Wolfe CM; Playso BE; Biedrzycki RJ; Lu Y; Nam KN; Lefterov I; Koldamova R
Mol Neurodegener; 2020 Jul; 15(1):41. PubMed ID: 32703241
[TBL] [Abstract][Full Text] [Related]
12. Opposing roles of the triggering receptor expressed on myeloid cells 2 and triggering receptor expressed on myeloid cells-like transcript 2 in microglia activation.
Zheng H; Liu CC; Atagi Y; Chen XF; Jia L; Yang L; He W; Zhang X; Kang SS; Rosenberry TL; Fryer JD; Zhang YW; Xu H; Bu G
Neurobiol Aging; 2016 Jun; 42():132-41. PubMed ID: 27143430
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2).
Atagi Y; Liu CC; Painter MM; Chen XF; Verbeeck C; Zheng H; Li X; Rademakers R; Kang SS; Xu H; Younkin S; Das P; Fryer JD; Bu G
J Biol Chem; 2015 Oct; 290(43):26043-50. PubMed ID: 26374899
[TBL] [Abstract][Full Text] [Related]
14. Intersection of pathological tau and microglia at the synapse.
Vogels T; Murgoci AN; Hromádka T
Acta Neuropathol Commun; 2019 Jul; 7(1):109. PubMed ID: 31277708
[TBL] [Abstract][Full Text] [Related]
15. Microglia and Aging: The Role of the TREM2-DAP12 and CX3CL1-CX3CR1 Axes.
Mecca C; Giambanco I; Donato R; Arcuri C
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29361745
[TBL] [Abstract][Full Text] [Related]
16. TREM2-induced activation of microglia contributes to synaptic integrity in cognitively intact aged individuals with Alzheimer's neuropathology.
Fracassi A; Marcatti M; Tumurbaatar B; Woltjer R; Moreno S; Taglialatela G
Brain Pathol; 2023 Jan; 33(1):e13108. PubMed ID: 35816404
[TBL] [Abstract][Full Text] [Related]
17. TNF-α-mediated reduction in inhibitory neurotransmission precedes sporadic Alzheimer's disease pathology in young Trem2
Ren S; Breuillaud L; Yao W; Yin T; Norris KA; Zehntner SP; D'Adamio L
J Biol Chem; 2021; 296():100089. PubMed ID: 33434745
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of TREM2 ameliorates neuropathology and rescues spatial cognitive impairment in a transgenic mouse model of Alzheimer's disease.
Jiang T; Tan L; Zhu XC; Zhang QQ; Cao L; Tan MS; Gu LZ; Wang HF; Ding ZZ; Zhang YD; Yu JT
Neuropsychopharmacology; 2014 Dec; 39(13):2949-62. PubMed ID: 25047746
[TBL] [Abstract][Full Text] [Related]
19. TREM2, Microglia, and Neurodegenerative Diseases.
Yeh FL; Hansen DV; Sheng M
Trends Mol Med; 2017 Jun; 23(6):512-533. PubMed ID: 28442216
[TBL] [Abstract][Full Text] [Related]
20. Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight.
Shi Y; Holtzman DM
Nat Rev Immunol; 2018 Dec; 18(12):759-772. PubMed ID: 30140051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
